Earn CE/CME Release date: March 1, 2020
Expiration date: March 31, 2021
Seeing is Believing ACTIVITY DESCRIPTION
INTENDED AUDIENCES
Routine screening colonoscopy with polypectomy is the most effective strategy for the prevention and early detection of colorectal cancer (CRC). Advantages include direct mucosal inspection of the entire colon and the ability to detect and remove precancerous polyps during a single session. Widespread use of this technique has contributed to an accelerating rate of decline in both the incidence and mortality of CRC from peak levels in the mid-1980s. Recently, noninvasive, home-based CRC detection tests have become available. One of the most important motivators for patient compliance with CRC screening guidelines is a recommendation from a primary care physician (PCP). The PCP has a unique opportunity to facilitate evidence-based and individualized screening in appropriate populations during regular checkups, in collaboration with specialists, and through appropriate referral and patient education. In this activity, participants will review the advantages and disadvantages of various CRC screening modalities and ways to maximize the effectiveness of the interdisciplinary team in delivering appropriate colonoscopy screening.
The intended audience for this activity comprises gastroenterologists and other health care professionals interested in CRC screening, colonoscopy, and appropriate bowel preparation.
GOAL The goal of this activity is to educate health care professionals about the use of appropriate CRC screening methods, including the limitations and advantages of both colonoscopic and noncolonoscopic approaches.
LEARNING OBJECTIVES 1. Review data supporting the importance of visualization via colonoscopy in the detection of CRC and precancerous polyps 2. Discuss the benefits and risks associated with the use of noncolonoscopic screening tests in the detection of CRC and precancerous polyps 3. Describe the role of the PCP in providing/referring for guideline-recommended CRC screening via colonoscopy
FACULTY Douglas K. Rex, MD, MACG, FASGE, MACP, AGAF Distinguished Professor of Medicine Indiana University School of Medicine Chancellors Professor Indiana University Purdue University of Indianapolis Director of Endoscopy Indiana University Hospital Indianapolis, Indiana
David A. Johnson, MD, MACG, FASGE, MACP Professor of Medicine Chief of Gastroenterology Eastern Virginia Medical School Norfolk, Virginia
Bill H. McCarberg, MD, FABM Kaiser Permanente San Diego (retired) Adjunct Assistant Clinical Professor University of California San Diego, California
Jointly provided by Global Education Group and Applied Clinical Education
ACCREDITATION AND CREDIT DESIGNATION STATEMENTS Physician Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group and Applied Clinical Education. Global Education Group is accredited by the ACCME to provide continuing medical education for physicians. Physician Credit Designation Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing Continuing Education Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity for 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
FEES: Free METHOD OF PARTICIPATION To receive CME credit, participants should read the preamble, participate in the activity, and complete the post-test and activity evaluation at www.cmezone.com/CU201. CME certificates will be made available immediately upon successful completion.
DISCLOSURE OF CONFLICTS OF INTEREST Global Education Group requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this activity: • David A. Johnson, MD, MACG, FASGE, MACP: Aries Pharmaceuticals, Avrio Health, CRH Medical, Medscape/ WebMD (consultant/independent contractor); CRH Medical (stock shareholder) • Bill H. McCarberg, MD, FABM: Adapt, Scilex (speakers bureaus); Collegium, Johnson and Johnson, Sellas Life Sciences (stock shareholder); Averitas, Lilly, Scilex (consultant/independent contractor)
Supported by an educational grant from Braintree, A Part of Sebela Pharmaceuticals.
• Douglas K. Rex, MD, MACG, FASGE, MACP, AGAF: Aries Pharmaceutical, Boston Scientific, Braintree Laboratories, Endokey, GI Supply, Lumendi Ltd, Medtronic, Norgine, Olympus Corporation (consultant/independent contractor); EndoAid Ltd, Erbe USA Inc, Olympus Corporation, Medivators Inc (grant/research support); Satisfai Health (ownership) The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: • Kathleen Wildasin: Nothing to disclose • Jennifer Kulpa: Nothing to disclose • Andrea Funk: Nothing to disclose • Lindsay Borvansky: Nothing to disclose • Ashley Marostica, RN, MSN: Nothing to disclose
DISCLOSURE OF UNLABELED USE This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and ACE do not recommend the use of any agent outside of the labeled indications. The opinions expressed in this activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER Participants have an implied responsibility to use newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or courses of diagnosis or treatment discussed should not be used by clinicians without evaluation of patient conditions, contraindications, applicable manufacturer’s product information, and the recommendations of other authorities.
GLOBAL CONTACT INFORMATION For information about the accreditation of this program, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.
Distributed by Gastroenterology & Endoscopy News, Priority Report, and CMEZone.com
